<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>China Fabricante de productos qu&#xED;micos</provider_name><provider_url>https://longchangextracts.com/es</provider_url><author_name>longcha9</author_name><author_url>https://longchangextracts.com/es/author/longcha9/</author_url><title>Naringin improves renal fibrosis in diabetes nephropathy mice by downregulating RhoA/ROCK signaling pathway - China Chemical Manufacturer</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="BsUtIwCIIt"&gt;&lt;a href="https://longchangextracts.com/es/la-naringina-mejora-la-fibrosis-renal/"&gt;La naringina mejora la fibrosis renal en ratones con nefropat&#xED;a diab&#xE9;tica mediante la regulaci&#xF3;n a la baja de la v&#xED;a de se&#xF1;alizaci&#xF3;n RhoA/ROCK&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://longchangextracts.com/es/la-naringina-mejora-la-fibrosis-renal/embed/#?secret=BsUtIwCIIt" width="600" height="338" title=""Naringina mejora la fibrosis renal en ratones con nefropat&#xED;a diab&#xE9;tica mediante la regulaci&#xF3;n a la baja de la v&#xED;a de se&#xF1;alizaci&#xF3;n RhoA/ROCK" - China Fabricante de Productos Qu&#xED;micos" data-secret="BsUtIwCIIt" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;</html><description>Diabetes nephropathy (DN) is the most common microvascular complication of diabetes and the most common cause of end-stage renal disease (ESRD). The current pathogenesis of diabetic nephropathy is complex, involving changes in renal hemodynamics, ischemia, oxidative stress, inflammatory activation, and activation of the renin angiotensin aldosterone system (RAAS), leading to renal fibrosis and ultimately affecting [&hellip;]</description></oembed>
